Blue Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Blue Trust's BMY Position: Q3 2026 in Review
Blue Trust reduced its Bristol-Myers Squibb (BMY) stake by 26% in Q3 2026, selling an estimated $264K and leaving 11,990 shares worth $748K. The position accounts for 0.01% of the portfolio, ranked #365.
Blue Trust first reported a position in BMY in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.48M in Q1 2023. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Blue Trust held 11,990 shares of Bristol-Myers Squibb worth $748K as of Q3 2026.
- Blue Trust sold 4,178 Bristol-Myers Squibb shares in Q3 2026, an estimated $264K.
- Bristol-Myers Squibb made up 0.01% of Blue Trust's portfolio in Q3 2026, its #365 holding.
- Blue Trust first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Bristol-Myers Squibb position peaked at $1.48M in Q1 2023.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.